Efficacy, safety of switching to latanoprostene bunod 0.024% in patients with OAG and OHT
Ophthalmology Times,
The switch may produce an additional 25% IOP reduction in mild to moderate forms of disease (Image Credit: AdobeStock/Davizro…
The switch may produce an additional 25% IOP reduction in mild to moderate forms of disease (Image Credit: AdobeStock/Davizro…
Constance O. Okeke ORLANDO, Fla. – Fixed combination therapies, new single agents with targeted mechanisms of action, laser…